Pharma Problems:

• India has large number of drug formulations : 60000 to 85000 
• Indian pharma industry thrives on production of cheap generic drugs that are copies of off patent medicines.
• India produces 1/5th of generic medicines globally.
• Such massive consumption could lead to body getting immune to medicnes effect and along with risk of side effects on vital organs
• Total of 963 drugs have been classified as Fixed Dosage Combination (FDC)
• FDC includes 2 or more active pharma ingredients combined in a single dosage form.
• Out of this 963, 344 drugs have been banned with effect from 10th March 2016, valued at Rs.3049 crs.
• If all the 963 drugs were banned, sales would have fallen by Rs.10000 Crs.
• US FDA has banned more than 40 pharma plants in India and issued around 50 warning letters, of which 1/3rd warning letters have been resolved.
• Current size of Indian pharma sales : US $ 18 billion. Currently 85% of API imported from China
• With Make in India flavour and reduced imports, in 2018, size of indian pharma is expected to touch US$ 48 billion
• In 2020, size is expected to be US$ 55 billion
• In 2025, the indian pharma market is expected to grow to RS$100 billion
• Currently 85% of API imported from China